Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytomegalovirus infection.

W E Aulitzky1, P Hengster, H Tilg

  • 1Department for Internal Medicine, University Hospital, Innsbruck.

Wiener Klinische Wochenschrift
|January 22, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In-utero fetal resuscitation during fetal blood transfusion for severe fetal erythroblastosis developed after chorionic villus sampling.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2024
Same author

Virtual reality cricothyrotomy - a case-control study on gamification in emergency education.

BMC medical education·2024
Same author

In-situ alignment of 3D printed anisotropic hard magnets.

Scientific reports·2022
Same author

FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

The Danish STR sequence database: duplicate typing of 363 Danes with the ForenSeq™ DNA Signature Prep Kit.

International journal of legal medicine·2018
Same journal

[Vaccination of immunocompromised individuals: Expert opinion - update 2026].

Wiener klinische Wochenschrift·2026
Same journal

Systematic review of clinical evidence for Kneipp medicine.

Wiener klinische Wochenschrift·2026
Same journal

Pelvic resections in primary sarcomas : Surgical outcomes and survival analysis of 75 patients.

Wiener klinische Wochenschrift·2026
Same journal

Jungmediziner*innen am Start: 11. Workshop für den medizinischen Nachwuchs.

Wiener klinische Wochenschrift·2026
Same journal

Stellungnahme der ÖGP zur geplanten Gesetzesnovelle zum Nichtraucherschutzgesetz.

Wiener klinische Wochenschrift·2026
Same journal

MUW researcher of the month: Dr. Moritz Schaefer.

Wiener klinische Wochenschrift·2026
See all related articles

Cytomegalovirus (CMV) infections are increasingly concerning in immunocompromised individuals and newborns. Advances in understanding CMV persistence and antiviral treatments offer new hope for managing these significant public health challenges.

Area of Science:

  • Virology
  • Immunology
  • Public Health

Background:

  • Cytomegalovirus (CMV) infections are gaining attention due to rising numbers in immunocompromised populations.
  • Recent research has elucidated mechanisms behind persistent and recurrent CMV infections.
  • CMV poses significant risks, particularly in bone marrow transplant recipients and AIDS patients.

Purpose of the Study:

  • To review the current understanding of cytomegalovirus (CMV) infections.
  • To highlight the clinical significance of CMV in different patient groups.
  • To discuss advancements in the treatment of CMV infections.

Main Methods:

  • Literature review of recent advances in CMV research.
  • Analysis of clinical presentations and public health implications of CMV.

Related Experiment Videos

  • Evaluation of current treatment strategies for CMV infections.

    • Main Results:

    • CMV infections manifest differently in healthy individuals versus immunocompromised patients.
    • CMV is a leading cause of mortality in certain immunocompromised groups.
    • Congenital and perinatal CMV infections represent major public health concerns.
    • Inhibitors of viral replication show promise in treating CMV in immunocompromised patients.

    Conclusions:

    • CMV infection management requires tailored approaches based on patient immune status.
    • Continued research into CMV pathogenesis and treatment is crucial.
    • Addressing congenital and perinatal CMV is essential for public health initiatives.